Finian McGrath (Dublin Bay North, Independent) | Oireachtas source

In summary, in reviewing the availability of these products, the HSE must be satisfied that the expected offset reductions in glucose monitoring ancillaries materialise. It was anticipated that offset efficiencies would materialise to improve affordability and this is a very important aspect of the HSE's consideration of whether further expectations are possible within current financial resources. However, the process also allows for patient experience and societal aspects of benefit to be considered, including improvements in health outcomes and quality of life. In reply to the Senator's specific question, no, I would not accept that indication if I were in that situation. I will raise this issue again with the HSE. The key section of the response outlines that societal aspects of benefits can be considered. All patients should be treated with respect and dignity. I will relay the Senator's concerns to the HSE.